Physicochemical Properties
| Molecular Formula | C20H16O2S |
| Molecular Weight | 320.404844284058 |
| Exact Mass | 320.09 |
| Elemental Analysis | C, 74.97; H, 5.03; O, 9.99; S, 10.01 |
| CAS # | 1666119-75-0 |
| PubChem CID | 5344692 |
| Appearance | White to off-white solid powder |
| LogP | 5.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 23 |
| Complexity | 392 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(C1SC=CC=1)(=O)/C=C/C1=CC=C(OCC2=CC=CC=C2)C=C1 |
| InChi Key | MKSMRBDQELHEBO-JLHYYAGUSA-N |
| InChi Code | InChI=1S/C20H16O2S/c21-19(20-7-4-14-23-20)13-10-16-8-11-18(12-9-16)22-15-17-5-2-1-3-6-17/h1-14H,15H2/b13-10+ |
| Chemical Name | 2-Propen-1-one, 3-[4-(phenylmethoxy)phenyl]-1-(2-thienyl)-, (2E)- |
| Synonyms | NSC321039; NSC-321039; NSC 321039; hMAO-B-IN-4; |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | hMAO-B-IN-4 (0-40 μM), which has a SI value of 504.791[1], exhibits higher selectivity for hMAO-B than hMAO-A. With IC50 values of 33.821 and 0.067 μM, respectively, hMAO-B-IN-4 (0-40 μM) inhibits hMAO-A and hMAO-B. |
| References |
[1]. Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors. Sci Rep. 2022 Dec 27;12(1):22404. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~50 mg/mL (~156.05 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.80 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.1211 mL | 15.6055 mL | 31.2110 mL | |
| 5 mM | 0.6242 mL | 3.1211 mL | 6.2422 mL | |
| 10 mM | 0.3121 mL | 1.5605 mL | 3.1211 mL |